Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use.

ABSTRACT:

Background

Despite evidence that individuals with opioid use disorder (OUD) have a lower risk of mortality when using evidence-based medications for OUD (MOUD), only 20 % of people with OUD receive MOUD. Black patients are significantly less likely than White patients to initiate MOUD. We measured the association between various facilitators and barriers to initiation, including criminal justice, human services, and health care factors, and variation in initiation of MOUD by race.

Methods

We used data from a comprehensive, linked data set of health care, human services, and criminal justice programs from Allegheny County in Western Pennsylvania to measure disparities in MOUD initiation by race in the first 180 days after an OUD diagnosis, as well as mediation by potential fa

SUBMITTER: Hollander MAG 

PROVIDER: S-EPMC8464525 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature